Singh, Dave
D’Urzo, Anthony D.
Donohue, James F.
Kerwin, Edward M.
Funding for this research was provided by:
AstraZeneca (N/A)
Article History
Received: 5 March 2019
Accepted: 24 June 2019
First Online: 8 July 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: DS has received research, consulting and lecturing fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Genentech, GlaxoSmithKline, Glenmark, Menarini, Mundipharma, Novartis, Peptinnovate, Pfizer, Pulmatrix, Therevance, and Verona. AD has received research, consulting and lecturing fees from Boehringer Ingelheim (Canada), and Novartis Canada. JD has received research, consulting and lecturing fees from AstraZeneca, GSK, Mylan, Sunovion, and Theravance. EK has received research, consulting and lecturing fees from Amphastar, AstraZeneca, Boehringer Ingelheim, Crisor LLC Research, GlaxoSmithKline, Mylan, Novartis, Oriel, Pearl, Sunovion, Teva, and Theravance.